Lupus is a long-term autoimmune disease that sadly does not have a cure yet. While people who have this condition are unlikely to die because of it, the complications that tend to develop in relation to the disease could be life-threatening.
For normal people, the battle against lupus is personal and out of the public eye. But for celebrities, having this autoimmune disease can be a cross to bear. Apart from working in the spotlight and being subjected to the scrutiny of the public, their personal struggles to manage the condition are magnified.
However, celebrities opening up about their battle against lupus can also be a good thing because more people will become aware of the disease and its symptoms, leading to early diagnosis in people who may not be aware that they have the autoimmune disease.
ImmuPharma PLC (LON:IMM) is headquartered in London and has its research operations in France (ImmuPharma (France) SA) and Switzerland (ImmuPharma AG). ImmuPharma is dedicated to the development of innovative drugs to treat serious medical conditions, characterised by High unmet medical need,Low marketing costs and Relatively low development costs